UV TMR stands for Ultraviolet Transmyocardial Revascularization, a laser-based heart procedure designed to relieve severe chest pain (angina) in patients who can’t be treated with traditional bypass surgery or stents. The procedure uses an ultraviolet excimer laser to create tiny channels directly through the heart muscle, allowing oxygen-rich blood to reach starved tissue through a new route.
How UV TMR Works
During the procedure, a surgeon uses laser energy to drill a series of 1-millimeter channels from the outer surface of the heart through the muscle wall and into the left ventricle, which is the heart’s main pumping chamber. Because the left ventricle is always filled with oxygenated blood, these channels create direct pathways for that blood to flow into areas of the heart muscle that aren’t getting enough supply through clogged or narrowed arteries.
The “UV” part matters because the type of laser used makes a difference. An excimer laser operates in the ultraviolet spectrum, which removes tissue through a cool, precise process rather than burning through it with heat. This matters for healing. Compared to other laser types used in TMR, the excimer laser causes less thermal damage to surrounding tissue, which means less scarring. Less scarring translates to a better healing response and a greater chance that the channels stay open over time. The cooler process also reduces the risk of air bubbles entering the bloodstream, which can cause stroke.
Beyond the channels themselves, the laser energy appears to trigger the growth of new tiny blood vessels in the treated area, a process called angiogenesis. Some researchers believe this new blood vessel growth is actually the more important long-term benefit, even more so than the channels staying physically open.
Who Qualifies for UV TMR
UV TMR is not a first-line treatment. It’s reserved for a specific group of patients whose chest pain hasn’t responded to other options. According to criteria outlined by the American College of Cardiology, candidates typically have refractory angina, meaning persistent chest pain that medications can’t adequately control, caused by coronary artery disease that’s too widespread or located in vessels too small to treat with bypass grafts or stents.
To qualify, patients generally need to show reversible blood flow problems on a heart perfusion scan, confirming that areas of the heart muscle are temporarily starved of oxygen during exertion but not permanently dead. Several conditions disqualify someone from the procedure:
- Viable bypass or stent options: If conventional revascularization can work, it’s preferred over TMR.
- Severely weakened heart: Patients whose heart pumps less than 30% of its blood volume per beat are excluded, as the procedure’s risks outweigh its benefits in that group.
- Inability to exercise: Candidates need to be able to walk on a treadmill, since that’s how doctors measure whether the procedure improved their condition.
- Dependence on IV heart medications: Patients who require continuous intravenous drugs for their angina are too unstable for the procedure.
- Limited life expectancy: Patients expected to live less than 12 months due to another condition are not considered candidates.
What the Procedure Looks Like
UV TMR is a surgical procedure, but it’s less invasive than open-heart bypass surgery. The surgeon accesses the heart through a small incision on the left side of the chest rather than cracking the sternum. The laser is then positioned against the beating heart, and channels are created one at a time. Each pulse of the laser is synchronized with the heartbeat, firing between beats to minimize disruption to the heart’s rhythm. The whole process typically creates between 15 and 40 channels, depending on the size of the oxygen-starved area.
Recovery is faster than traditional bypass surgery, though patients still spend several days in the hospital and need weeks to return to normal activity. The primary goal is pain relief. Most patients undergo TMR hoping to reduce the frequency and severity of their angina episodes, improve their ability to exercise, and rely less on medication.
Long-Term Results
Research from Johns Hopkins tracking patients for up to seven years after TMR found that, while different laser types (including the UV excimer) were compared, there were no clinically meaningful differences in long-term outcomes between them. This suggests that the benefits of TMR as a technique are fairly consistent regardless of which laser is used, though the UV excimer’s lower scarring and reduced stroke risk remain potential advantages during and immediately after the procedure.
The most consistent benefit seen across TMR studies is angina relief. Many patients report dropping from severe, daily chest pain to mild or infrequent episodes. The results for hard outcomes like survival are less dramatic, and TMR has not been shown to prevent heart attacks or significantly extend life. It is, at its core, a quality-of-life procedure for people who have run out of conventional options.